Indivior Pharmaceuticals, Inc. INDV Business Segments — Interest Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's business segments — interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's business segments — interest expense?
- Indivior Pharmaceuticals, Inc. (INDV) reported business segments — interest expense of $7M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's business segments — interest expense changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's business segments — interest expense decreased by 41.7% year-over-year, from $12M to $7M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's business segments — interest expense?
- Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's business segments — interest expense has grown at a 18.6% compound annual growth rate (CAGR), from $27M to $45M.
- What does business segments — interest expense mean?
- Represents the cost of debt financing incurred by the segment, including interest on loans and other financial obligations. This metric is vital for evaluating the segment's leverage and the impact of financing costs on overall profitability.